Tag: Infectious Disease Prevention
FDA Approves Moderna’s mFLUSIVA, the First mRNA-Based Seasonal Influenza Vaccine
Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), making it the first mRNA-based vaccine approved for seasonal influenza.
The vaccine...
KM Biologics and Serum Institute of India Enter Strategic Partnership to Enhance Global Access to Japanese Encephalitis Vaccines
Meiji Seika Pharma Co., Ltd. announced that its subsidiary, KM Biologics Co., Ltd., has achieved the first technical milestone in its strategic collaboration with...
